BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK)
BioSpace (DHX) Poll Finds Whopping 92% of Respondents Believe Discounts Were Offered in Pricing War
Hidden Spy Camera Discovered in Johnson & Johnson (JNJ) Bathroom, Say Police
Pfizer (PFE)'s $33 Billion Cash Pile Has Everyone Speculating
Actavis (ACT)' Buying Spree Continues With $460 Million Deal
Shire (SHPGY)'s $5.2 Billion Bet Pays Off as NPS Pharmaceuticals, Inc. (NPSP)'s Natpara Wins Approval
Pressure Lead Pfizer (PFE) CEO to Approach Teva Pharmaceutical Industries Limited (TEVA) Late Last Year
FDA Says Yes to Rockwell Medical (RMTI)'s Iron Replacement Drug
Regeneron (REGN)-Sanofi (SAN.PA) Gain Edge On Amgen (AMGN) as Cholesterol Drug Snags FDA Priority Review
Thousands Sign Petition Against AstraZeneca PLC (AZN)'s Plans for Animal R&D Lab in Cambridge
Ousted Sanofi (SAN.PA) CEO Pockets $5 Million+ Severance Package
After Gilead Sciences, Inc. (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next
FDA Approves Novartis AG (NVS)'s Cosentyx for Painful Skin Disease
Huge Payday Looming for Six Auxilium Pharmaceuticals (AUXL) Execs
Takeda (TKPYY) COO Was Approached for Sanofi (SAN.PA) CEO Job But Declined
Novartis AG (NVS) CEO Taking a Hard Look at Swiss Costs, Possible Bolt-On Acquisitions
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China
FDA Panel Backs Astellas Pharma Inc. (ALPMY)'s CRESEMBA for Invasive Fungal Infections
See All News >
//-->